展品107
申報費用計算表格
表格 S-1
BioAge Labs, Inc.
表一 — 新註冊證券
| 證券 類型 |
證券 Class A普通股 標題 |
費用 計算 規則 |
金額 已註冊(1) |
建議 每股發售價格 |
最高 價格(1)(2) |
費用 利率 |
金額
的 費用 | |||||||||
| 費用 将要 已付款 |
股權 | 普通股票， 面額 每股$0.00001 |
規則457(a) | 575,000 | $18.00 | 10,350,000 | $0.00014760 | 1,528 | ||||||||
| 發行總金額 | 10,350,000 | — | 1,528 | |||||||||||||
| 總費用抵銷額 | — | — | — | |||||||||||||
| 應付淨費用 | — | — | 1,528 | |||||||||||||
| (1) | Represents 575,000 additional shares of common stock being registered, including 75,000 additional shares to cover the underwriters’ option to purchase additional shares in full. Does not include the securities that the Registrant previously registered on the Registration Statement on Form S-1, as amended (333-281901). |
| (2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(a) under the Securities Act of 1933, as amended (the Securities Act). The Registrant previously registered 12,075,000 shares of its common stock with an aggregate offering price not to exceed $229,425,000 on a Registration Statement on Form S-1, 年修正案（編號 No. 333-281901), which was declared effective by the Securities and Exchange Commission on September 25, 2024. In accordance with Rule 462(b) under the Securities Act, an additional amount of shares having a proposed maximum aggregate offering price of $18.00 are hereby registered, which includes the additional shares that the underwriters have the option to purchase. |